Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenton, S. E.
Right arrow Articles by Sheffield, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenton, S. E.
Right arrow Articles by Sheffield, L. G.

Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function

SE Fenton and LG Sheffield

Endocrinology-Reproductive Physiology Program, University of Wisconsin- Madison 53706.

We have previously shown that lactogenic hormones stimulate epidermal growth factor (EGF) mRNA accumulation in mouse mammary glands in vivo and in mouse mammary epithelial cells (NMuMG line). However, our in vitro studies indicate that the lactogenic hormone prolactin (PRL) completely inhibits EGF-stimulated DNA synthesis. PRL does not alter cholera toxin or insulin-like growth factor-1-stimulated cell growth, thus the inhibition appears to be specific for EGF. Our current studies are designed to evaluate the effects of PRL on EGF-stimulated signaling events in the NMuMG cell line. Cells treated with PRL for 30 min demonstrated a loss of high affinity EGF-binding ability. After long- term PRL treatment (18 h) there was a decrease in EGF receptor (R) number, as determined by [125I]EGF binding. PRL treatment (8 h) also decreased EGF-R mRNA levels. An EGF-stimulated increase in EGF-R mRNA observed 2-4 h after treatment was decreased when PRL was added to the cultures. Furthermore, levels of EGF-stimulated tyrosine phosphorylation of the EGF-R (170 kDa) and phospholipase C gamma (145 kDa) are dramatically decreased in cells treated with PRL. Also of great interest was a decrease in EGF-stimulated c-myc mRNA in PRL- treated cells. We conclude that PRL is acting to down-regulate the EGF- R, thus limiting EGF-stimulated cell signaling in mammary tissue.

Volume 4, Issue 8, pp. 773-780, 08/01/1993
Copyright © 1993 by The American Society for Cell Biology




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
M. A. Rycyzyn, S. C. Reilly, K. O’Malley, and C. V. Clevenger
Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation
Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
L. G. Sheffield
Hormonal Regulation of Epidermal Growth Factor Receptor Content and Signaling in Bovine Mammary Tissue
Endocrinology, November 1, 1998; 139(11): 4568 - 4575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. J. Quijano Jr. and L. G. Sheffield
Prolactin Decreases Epidermal Growth Factor Receptor Kinase Activity via a Phosphorylation-dependent Mechanism
J. Biol. Chem., January 9, 1998; 273(2): 1200 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Johnson, S. Fenton, and L. G. Sheffield
Prolactin Inhibits Epidermal Growth Factor-induced Ras-MAPK Signaling in Mammary Epithelial Cells
J. Biol. Chem., August 30, 1996; 271(35): 21574 - 21578.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]